v3.19.1
Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash Flows from Operating Activities:    
Net loss $ (4,900) $ (5,021)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:    
Depreciation and amortization 258 264
Provision for bad debts, net 19 200
Provision for sales allowance   4
Amortization of discounts on lines of credit 38  
Amortization of debt issuance costs 49 7
Stock-based compensation 757 701
Deferred income taxes (5) 2
Earned interest income, net (1) (1)
Change in fair value of patent litigation settlement liability 190  
Changes in operating assets and liabilities:    
Accounts receivable (650) 186
Inventory 225 (1,103)
Prepaid expenses and other current assets 463 (20)
Accounts payable and accrued liabilities (1,514) 460
Deferred revenue 37 (441)
Net cash and cash equivalents used in operating activities (5,034) (4,762)
Cash Flows from Investing Activities:    
Purchases of property, plant, and equipment (8) (102)
Net cash and cash equivalents used in investing activities (8) (102)
Cash Flows from Financing Activities:    
Principal payments under capital lease obligation   (46)
Borrowings under lines of credit   1,823
Payments of debt issuance costs   (74)
Payments of equity offering costs   (81)
Proceeds from exercise of stock options 3 2
Net cash and cash equivalents provided by financing activities 3 1,624
Effect of exchange rate changes (49) 74
Decrease in cash, cash equivalents and restricted cash (5,088) (3,166)
Cash, cash equivalents and restricted cash, beginning of period 8,356 11,896
Cash, cash equivalents and restricted cash, end of period 3,268 8,730
Supplemental cash flow disclosure:    
Cash paid for interest 430  
Cash paid for income taxes 31 24
Cash paid for operating leases 189  
Non-cash accrual for capital expenditures 24 $ 4
Non-cash right-of-use assets obtained in exchange for lease obligation $ 824  

Source